FDA Approves Lucemyra™ for Opioid Withdrawal Symptoms
carmahealth2024-04-22T14:24:03-05:00FDA Approves Lucemyra™ for Opioid Withdrawal Symptoms In a landmark moment for opioid addiction relapse prevention, the Food and Drug Administration (FDA) has approved the first-ever non-opioid medication to treat opioid withdrawal. The agency has expedited approval of Lucemyra™ (lofexidine hydrochloride) on May 16, 2018. Originally developed to treat [...]